Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Simlandi® (adalimumab-ryvk) – New biosimilar launch

May 20, 2024 - Alvotech and Teva launched Simlandi (adalimumab-ryvk), an interchangeable biosimilar to AbbVie’s Humira® (adalimumab).

Download PDF

 

Rx navigation